Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Komi Hakko Corporation is active in the Biotechnology & Pharmaceuticals technology area, where it currently has 1 pending office action. This matter is assigned to 1 distinct examiner, indicating a specific area of inquiry from the USPTO. The prosecution is further localized within 1 distinct art unit, which suggests the technical subject matter is specialized and falls within a narrow range of the biotechnology field.
Ruixiang Li serves as the busiest examiner for the company, with 1 busiest examiner pending office action. Because there is 1 pending office action in total, this examiner is responsible for the company's entire current pending docket. The prosecution strategy for Komi Hakko Corporation is therefore centered on addressing the specific requirements of this examiner within the biotechnology sector. Practitioners should focus on the examiner's specific technical expertise and the art unit's historical allowance rates to better predict the timeline and potential hurdles for this pending application.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LI, RUIXIANG | 1 | 59.5% | +18.6% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18303118 | METHOD FOR QUANTIFYING ODORS, CELLS USED IN SAME, AND METHOD FOR PRODUCING SAID CELLS | LI, RUIXIANG | — |
| Art Unit | Apps |
|---|---|
| 1674 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18303118 | METHOD FOR QUANTIFYING ODORS, CELLS USED IN SAME, AND METHOD FOR PRODUCING SAID CELLS | LI, RUIXIANG | 1674 | §103 | Final Rejection | — | Pending | Apr 19, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial